Very recent works performed by two independent groups further revealed that the CD133+ cell population in GBM contains a subset of vascular endothelial cadherin (CD144)-positive cells showing CSCs characteristics and capable of de novo tumor vascularization through direct differentiation into endothelial cells [116, 117]. The gene discussed is PROM1; the disease is glioblastoma.